We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Innovative Chemistry Set Applies Coloring-Book Approach to Perform Life-Saving Tests

By LabMedica International staff writers
Posted on 18 May 2015
Scientists have developed a set of “reagent pencils” for solvent-free deposition of reagents onto paper-based microfluidic devices that offers a new option for simple, customized point-of-care diagnostics, and other chemical testing applications.

A doctor scribbling on a notepad may soon be not only for medical notes, but also for real-time chemical preparations for a rapid diagnostic test. More...
Researchers from California Polytechnic State University (San Luis Obispo, CA, USA) have developed reagent pencils with chemicals formed into pencils to test reactions by simply drawing on specialized paper then adding water, upon which the reagents dissolve from the pencil matrix and become available to react with analytes in the sample.

The project began with the established technique of paper-based microfluidics that uses capillary action of paper to carefully mix together reagents. The established technique uses, for example, drops of two or more reagent solutions absorbed by a paper-based strip, spreading outward until they merge to form a mixture. In the new approach, the reagents are applied with reagent pencil instead of drops.

The pencils were prepared by pulverizing a mixture of graphite (as in normal pencils), test reagents, and polyethylene glycol, which helps keep the reagents dispersed (used for the same purpose in toothpaste). The mixture was compressed into pellets and mounted into mechanical pencil holders. The reaction-paper pad was prepared using a waxy ink to print small connected enclosures onto filter paper. The reagent pencils are used to color-in the areas within the enclosures. Upon adding water to the paper, the reagents dissolve and, confined by the waxy ink, are forced to diffuse towards one another.

The team demonstrated validity of a potential application by comparing to the colorimetric dropper test commonly used by diabetics to check their own blood glucose levels, which involves reacting a pinprick blood sample with a chemical solution. One pencil was constructed with a mixture of the enzymes horseradish peroxidase (HRP) and glucose oxidase (GOx). A second pencil contained ABTS. When combined in the presence of glucose these react to give a blue-colored product. The results were essentially the same accuracy and precision as the dropper method.

Set-up for this pad and pencil system requires only the skill of coloring within the lines, whereas the commonly used test requires significantly more training. And the reaction mix can be adjusted as necessary by simply applying more or less, without making up complex solutions.

Another advantage is that the reagents are extremely stable in the pencils – there was no sign of degradation after two months under ambient conditions, whereas in liquid form they usually degrade in days, limiting how and where the tests can be performed. The pencils kit is easily and stably transported.

In addition to diagnostic tests, the potential applications scope includes tests to monitor environmental pollutants and even new approaches to teaching chemistry and chemical testing in primary schools.

The study, by Mitchell HT et al, was published online April 8, 2015, in the journal Lab on a Chip.

Related Links:

California Polytechnic State University



Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Gold Member
Blood Gas Analyzer
Stat Profile pHOx
New
Candida Glabrata Test
ELIchrom Glabrata
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.